James B. Weissman, Chief Business Officer at Dicerna Pharmaceuticals Inc (DRNA), sold 15,000 shares at $15.00 ($225K) on 2019-04-02, disclosed to the SEC on 2019-04-04.
Open-market sale of $225k DRNA by Chief Business Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| DRNA | SELL | 2021-02-08 | $386K | — | Filing → |
| DRNA | SELL | 2021-01-12 | $91K | — | Filing → |
| DRNA | SELL | 2020-12-03 | $220K | — | Filing → |